|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 884.1 USD | -0.74% |
|
-1.47% | +0.61% |
| 06:25pm | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
| 02:45pm | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
Regeneron Pharmaceuticals, Inc.(NasdaqGS:REGN) added to Russell 1000 Dynamic Index
| 1st Jan change | Capi. | |
|---|---|---|
| +0.61% | 95.71B | |
| -2.24% | 103B | |
| +1.69% | 22.02B | |
| -16.77% | 20.9B | |
| -9.30% | 17.85B | |
| -41.01% | 16.21B | |
| -14.60% | 15.52B | |
| +3.32% | 13.86B | |
| +34.79% | 12.04B | |
| -25.22% | 8.08B |
REGENERON PHARMACEUTICALS, INC. 
